Search - tctmd.com

Displaying 141 - 160 of 164

Sort: Relevancy | Date

Presentation TCT 2014

The Five Echocardiographic Essentials for Optimal TAVR

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Multi-device Patient-Specific TAVR Now or in the Future?

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Raj Makkar

September 14, 2014

Presentation TCT 2014

Lessons From the CHOICE Trial

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Mohamed Abdel-Wahab

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, John G. Webb

September 14, 2014

Presentation TCT 2014

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

Presenter: Alain G. Cribier, Michael J. Reardon, Steven J. Yakubov, Nicolo Piazza

September 14, 2014

Presentation TCT 2014

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Presenter: Josep Rodés-Cabau, Mathew Williams, Azeem Latib, Michael J. Reardon

September 14, 2014

Presentation TVT 2014

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic is Clearly Superior to Transapical!

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Lotus - Status of the US Clinical Trial and Case Examples

Presenter: Ted E. Feldman, Michael J. Reardon

June 06, 2014

Presentation TVT 2014

The High-Risk Randomized Trial

Presenter: Michael J. Reardon

June 05, 2014

News Industry News

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

April 29, 2014

Partner Content

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

January 25, 2024

Partner Content

Building Your TAVR Program - Medtronic

October 31, 2019

Partner Content

The Foundations of TAVR - Medtronic

October 29, 2019

CME

Low-Risk Patients: The Changing Face of TAVR

CME

Updates on TAVR in Low-Risk Patients

CME

The Treatment of Mitral Regurgitation in 2019 and Beyond

Partner Content

Considerations for TAVR in Lower-Risk Patients

July 20, 2018

CME

Advertisement

The Five Echocardiographic Essentials for Optimal TAVR

Multi-device Patient-Specific TAVR Now or in the Future?

Lessons From the CHOICE Trial

Special Attributes and Disadvantages of the Balloon-Expandable TAVR Platform

Special Attributes and Disadvantages of the Self-Expanding TAVR Platform

TAVR Alternative Access: Balancing Risks and Benefits of Subclavian, Direct Aortic, and Transapical Approaches

Lessons Learned about Frailty and Comorbidities from the US CoreValve Trials

Direct Aortic is Clearly Superior to Transapical!

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Lotus - Status of the US Clinical Trial and Case Examples

The High-Risk Randomized Trial

Medtronic Reveals Positive Outcomes for CoreValve® Patients Treated via Alternative Access Routes

A Critical Assessment of Valve Performance and Outcomes in Patients at Low Risk for Surgery

Building Your TAVR Program - Medtronic

The Foundations of TAVR - Medtronic

Low-Risk Patients: The Changing Face of TAVR

Updates on TAVR in Low-Risk Patients

The Treatment of Mitral Regurgitation in 2019 and Beyond

Considerations for TAVR in Lower-Risk Patients

TAVR: The Heart Team Approach

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content